Could a pill combo replace chemo for some breast cancers?
Disease control
Ongoing
This study tests whether adding ribociclib to the hormone therapy letrozole for 24 weeks before surgery can improve outcomes for postmenopausal women with ER-positive, HER2-negative early breast cancer. The goal is to help more women achieve a low-risk score (PEPI 0) at surgery, …
Phase: PHASE2 • Sponsor: Qamar Khan • Aim: Disease control
Last updated May 11, 2026 20:48 UTC